Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 1170

1.

Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review.

Wilson RP, Bhattacharyya S.

J Psychopharmacol. 2016 Feb;30(2):99-111. doi: 10.1177/0269881115612237. Epub 2015 Oct 28. Review.

PMID:
26510450
2.

Neurological Adverse Effects of Antipsychotics in Children and Adolescents.

Garcia-Amador M, Merchán-Naranjo J, Tapia C, Moreno C, Castro-Fornieles J, Baeza I, de la Serna E, Alda JA, Muñoz D, Andrés Nestares P, Cantarero CM, Arango C.

J Clin Psychopharmacol. 2015 Dec;35(6):686-93. doi: 10.1097/JCP.0000000000000419.

PMID:
26505569
3.

Establishing the cut-off score for remission and severity-ranges on the Psychotic Depression Assessment Scale (PDAS).

Østergaard SD, Rothschild AJ, Flint AJ, Mulsant BH, Whyte EM, Vermeulen T, Bech P, Meyers BS.

J Affect Disord. 2016 Jan 15;190:111-4. doi: 10.1016/j.jad.2015.09.073. Epub 2015 Oct 22.

PMID:
26496016
4.

Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trial.

Conus P, Berk M, Cotton SM, Kader L, Macneil C, Hasty MK, Hallam K, Lambert M, Murphy BP, McGorry PD.

Eur Psychiatry. 2015 Nov;30(8):975-82. doi: 10.1016/j.eurpsy.2015.09.009. Epub 2015 Oct 21.

PMID:
26485297
5.

Anxiety in Patients with Schizophrenia: Epidemiology and Management.

Temmingh H, Stein DJ.

CNS Drugs. 2015 Oct 19. [Epub ahead of print]

PMID:
26482261
6.

Long-term effect of lithium maintenance therapy on estimated glomerular filtration rate in patients with affective disorders: a population-based cohort study.

Clos S, Rauchhaus P, Severn A, Cochrane L, Donnan PT.

Lancet Psychiatry. 2015 Dec;2(12):1075-83. doi: 10.1016/S2215-0366(15)00316-8. Epub 2015 Oct 6.

PMID:
26453408
7.

Management of primary negative symptoms in schizophrenia: an one-year observational study.

Franza F, Fasano V, De Guglielmo S, Solomita B.

Psychiatr Danub. 2015 Sep;27 Suppl 1:S245-9.

PMID:
26417773
8.

Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis.

Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, Rosenbaum S, Correll CU.

World Psychiatry. 2015 Oct;14(3):339-47. doi: 10.1002/wps.20252.

9.

Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study.

Vernal DL, Kapoor S, Al-Jadiri A, Sheridan EM, Borenstein Y, Mormando C, David L, Singh S, Seidman AJ, Carbon M, Gerstenberg M, Saito E, Kane JM, Steinhausen HC, Correll CU.

J Child Adolesc Psychopharmacol. 2015 Sep;25(7):535-47. doi: 10.1089/cap.2014.0164.

PMID:
26375767
10.

[Eating disorders in psychiatric patients during treatment with second generation antipsychotics].

Vasilenko LM, Gorobets LN, Bulanov VS, Litvinov AV, Ivanova GP, Tsarenko MA, Polyakovskaya TP.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(7):60-7. Russian.

PMID:
26356516
11.

A double amino-acid change in the HLA-A peptide-binding groove is associated with response to psychotropic treatment in patients with schizophrenia.

Le Clerc S, Taing L, Fond G, Meary A, Llorca PM, Blanc O, Beaune P, Rajagopal K, Jamain S, Tamouza R, Zagury JF, Leboyer M.

Transl Psychiatry. 2015 Jul 28;5:e608. doi: 10.1038/tp.2015.97.

PMID:
26218850
12.

Evolution of First-generation and Second-generation Antipsychotic Prescribing Patterns in Belgium Between 1997 and 2012: A Population-based Study.

Morrens M, Destoop M, Cleymans S, VAN DER Spek S, Dom G.

J Psychiatr Pract. 2015 Jul;21(4):248-58. doi: 10.1097/PRA.0000000000000085.

PMID:
26164050
13.

Investigation into effects of antipsychotics on ectonucleotidase and adenosine deaminase in zebrafish brain.

Seibt KJ, Oliveira Rda L, Bogo MR, Senger MR, Bonan CD.

Fish Physiol Biochem. 2015 Dec;41(6):1383-92. doi: 10.1007/s10695-015-0093-2. Epub 2015 Jul 9.

PMID:
26156500
14.

Improvements in body composition, anthropometric measurements and lipid profile following discontinuation of clozapine.

Wysokiński A, Sobów T.

Nord J Psychiatry. 2016 Feb;70(2):156-60. doi: 10.3109/08039488.2015.1056225. Epub 2015 Jul 3.

PMID:
26140393
15.

[Psychotic Disorder and Sheehan's Syndrome: Etiology or Comorbidity?: A Case Report].

Tıkır B, Göka E, Aydemir MÇ, Gürkan Ş.

Turk Psikiyatri Derg. 2015 Summer;26(2):142-5. Turkish.

16.

[Guidelines for the use of second-generation long-acting antipsychotics].

Jarema M, Wichniak A, Dudek D, Samochowiec J, Bieńkowski P, Rybakowski J.

Psychiatr Pol. 2015 Mar-Apr;49(2):225-41. doi: 10.12740/PP/39370. Polish.

17.

Psychotic syndrome secondary to meningioma treated with a low dose of olanzapine.

Maia-de-Oliveira JP, Brasileiro LE, Correia CE, Machado-de-Sousa JP, Hallak JE.

Rev Bras Psiquiatr. 2015 Apr-Jun;37(2):179-80. doi: 10.1590/1516-4446-2014-1550. Epub 2015 Apr 1. No abstract available.

18.

Adverse reactions to antipsychotics in Parkinson disease: an analysis of the Spanish pharmacovigilance database.

Lertxundi U, Ruiz AI, Aspiazu MÁ, Domingo-Echaburu S, García M, Aguirre C, García-Moncó JC.

Clin Neuropharmacol. 2015 May-Jun;38(3):69-84. doi: 10.1097/WNF.0000000000000080.

PMID:
25970275
19.

Antipsychotics inhibit glucose transport: Determination of olanzapine binding site in Staphylococcus epidermidis glucose/H(+) symporter.

Babkin P, George Thompson AM, Iancu CV, Walters DE, Choe JY.

FEBS Open Bio. 2015 Apr 15;5:335-40. doi: 10.1016/j.fob.2015.04.006. eCollection 2015.

20.

The HELPER programme: HEalthy Living and Prevention of Early Relapse – three exploratory randomised controlled trials of phase-specific interventions in first-episode psychosis.

Marshall M, Barrowclough C, Drake R, Husain N, Lobban F, Lovell K, Wearden A, Bradshaw T, Day C, Fitzsimmons M, Pedley R, Piccuci R, Picken A, Larkin W, Tomenson B, Warburton J, Gregg L.

Southampton (UK): NIHR Journals Library; 2015 Apr.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk